Acquired hemolytic anemia (DC 7723) | VA Rating Tool
| Diagnostic Code | 7723 |
|---|---|
| Category | The Hemic and Lymphatic Systems |
| Subcategory | The Hematologic and Lymphatic Systems |
| Also Known As | Acquired hemolytic anemia |
| CFR Section | 4.117 |
Next Steps for This Condition
Rating Criteria
| Rating | Criteria |
|---|---|
| 100% | Note (1): A 100 percent evaluation for bone marrow transplant shall be assigned as of the date of hospital admission and shall continue for six months after hospital discharge with a mandatory VA examination six months following hospital discharge. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter |
| 100% | Requiring a bone marrow transplant or continuous intravenous or immunosuppressive therapy (e.g., prednisone , Cytoxan, azathioprine , or rituximab ) |
| 60% | Requiring immunosuppressive medication 4 or more times per 12-month period |
| 30% | Requiring at least 2 but less than 4 courses of immunosuppressive therapy per 12-month period |
| 10% | Requiring one course of immunosuppressive therapy per 12-month period |
| 0% | Asymptomatic |